Introduction
Biphasic Insulin Aspart [rDNA] is a combination insulin formulation that combines both rapid-acting and intermediate-acting insulin. It is designed to manage blood glucose levels throughout the day by providing both immediate and extended glycemic control. This formulation is used in the treatment of type 1 and type 2 diabetes mellitus.
Uses
Biphasic Insulin Aspart is used for:
- Controlling blood glucose levels in patients with type 1 and type 2 diabetes mellitus.
- Providing a balanced approach to manage blood glucose levels both before and after meals.
- Reducing the frequency of insulin injections needed by combining both rapid- and intermediate-acting insulin in one formulation.
Mechanism of Action
The rapid-acting component of Biphasic Insulin Aspart works quickly to lower blood glucose levels by enhancing glucose uptake into cells and suppressing glucose production in the liver. The intermediate-acting component provides extended insulin action, helping to maintain glucose control over a longer period. This combination helps manage both postprandial and basal glucose levels.
How Long Does It Take to Work?
The rapid-acting component of Biphasic Insulin Aspart begins to work within 10 to 20 minutes after injection, with a peak effect occurring within 1 to 4 hours. The intermediate-acting component starts to work later, providing extended glucose control for up to 16 to 20 hours. The combined formulation provides coverage throughout the day and night.
Absorption
After subcutaneous injection, the rapid-acting insulin aspart is absorbed quickly into the bloodstream. The intermediate-acting insulin is absorbed more slowly due to its crystalline suspension with protamine. The combination allows for both immediate and prolonged glucose control. Absorption rates can vary depending on the injection site and individual patient factors.
Route of Elimination
Insulin aspart and the intermediate-acting component are metabolized primarily in the liver and kidneys. Insulin is broken down by insulinase and other proteolytic enzymes, with metabolites excreted in the urine. The intermediate-acting component, which includes protamine, is also metabolized and cleared through the kidneys.
Dosage
The dosage of Biphasic Insulin Aspart should be individualized based on the patient’s needs, blood glucose levels, and overall treatment goals. Typical dosing regimens may involve:
- Starting doses often range from 0.5 to 1 unit per kilogram of body weight per day, divided into 2 or more injections.
- Doses are usually administered before meals and may be adjusted based on regular monitoring of blood glucose levels and HbA1c.
Administration
Biphasic Insulin Aspart is administered subcutaneously. Common injection sites include the abdomen, thighs, or upper arms. It is important to rotate injection sites to prevent lipodystrophy and ensure consistent absorption. It is not intended for intravenous use. The medication should be injected at the same time each day to maintain consistent blood glucose control.
Side Effects
Common side effects include:
- Hypoglycemia (low blood sugar)
- Injection site reactions, such as pain, redness, or irritation
- Weight gain
Serious side effects can include:
- Severe hypoglycemia or hyperglycemia
- Allergic reactions, such as rash or swelling
- Hypokalemia (low potassium levels)
Toxicity
Toxicity is primarily due to overdose, resulting in severe hypoglycemia. Symptoms of hypoglycemia include confusion, dizziness, sweating, tremors, and loss of consciousness. Immediate treatment involves administering glucose orally or intravenously and monitoring the patient closely until blood glucose levels are stable.
Precautions
Precautions include:
- Careful monitoring of blood glucose levels to avoid hypoglycemia.
- Adjusting insulin doses in response to changes in diet, exercise, and overall health status.
- Monitoring for signs of allergic reactions or local reactions at the injection site.
Interaction
Drug interactions can occur with various medications, including:
- Oral hypoglycemic agents – may require dose adjustments to prevent hypoglycemia.
- Beta-blockers – can mask symptoms of hypoglycemia and affect glucose metabolism.
- Diuretics and corticosteroids – may increase blood glucose levels and affect insulin requirements.
Disease Interaction
Use with caution in patients with:
- Kidney or liver disease – may affect insulin metabolism and clearance.
- Severe infections or trauma – may require adjustments in insulin dosage due to altered glucose metabolism.
Drug Interaction
Potential drug interactions include:
- Drugs that affect glucose metabolism, such as corticosteroids or certain antihypertensives.
- Alcohol – can increase the risk of hypoglycemia or alter insulin effectiveness.
Food Interactions
Food intake can affect blood glucose levels and insulin requirements. It is important to maintain a consistent diet and monitor blood glucose levels regularly. Meals should be timed to correspond with insulin administration to avoid hypoglycemia or hyperglycemia.
Pregnancy Use
Biphasic Insulin Aspart is generally considered safe during pregnancy. However, insulin needs may change, and careful monitoring of blood glucose levels is required. Pregnant women should consult their healthcare provider for personalized recommendations and adjustments in dosage.
Lactation Use
Insulin aspart is excreted in breast milk in very small amounts, and its use during lactation is considered safe. However, monitoring of blood glucose levels is important for both the mother and the infant. Consult a healthcare provider for any specific concerns related to breastfeeding and insulin therapy.
Acute Overdose
An acute overdose of Biphasic Insulin Aspart can lead to severe hypoglycemia. Symptoms include confusion, sweating, rapid heartbeat, and loss of consciousness. Treatment involves administering glucose or glucagon and monitoring the patient closely until blood glucose levels stabilize.
Contraindication
Biphasic Insulin Aspart is contraindicated in patients with:
- Hypoglycemia or known hypersensitivity to insulin aspart.
- Severe insulin resistance or certain rare conditions that affect insulin utilization.
Use Direction
Follow the prescribed dosage and administration instructions carefully. Administer the medication subcutaneously and rotate injection sites to minimize local reactions. Regularly monitor blood glucose levels and adjust the dosage based on individual needs and response to treatment.
Storage Conditions
Store Biphasic Insulin Aspart in the refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. After opening, it can be stored at room temperature for up to 28 days. Protect from light and keep out of reach of children.
Volume of Distribution
The volume of distribution for insulin aspart is approximately 0.1 to 0.2 L/kg. The presence of the intermediate-acting component affects the distribution and prolongs the duration of action.
Half Life
The half-life of insulin aspart is approximately 1 to 2 hours, while the intermediate-acting component extends the duration of action. The combined formulation provides a duration of action of up to 16 to 20 hours, influenced by both components.
Clearance
Insulin aspart is cleared primarily through hepatic metabolism and renal excretion. The intermediate-acting component affects the clearance rate by slowing down the absorption and metabolism of insulin, thereby prolonging its action and maintaining blood glucose control.
